Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,026 GBX | -0.66% |
|
-2.82% | +13.28% |
03:10pm | AstraZeneca's Tagrisso Approved by EU as First-Line Treatment for Non-Small Cell Lung Cancer | MT |
01:39pm | AstraZeneca: cancer treatment approved by the EU | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.28% | 240B | |
+56.04% | 809B | |
+39.52% | 624B | |
-7.41% | 351B | |
+6.53% | 289B | |
+13.75% | 220B | |
-0.33% | 219B | |
+8.26% | 166B | |
-2.90% | 157B | |
+1.46% | 123B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- C4X Discovery Receives $11 Million Milestone Payment from AstraZeneca